NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,780,750 | +88.8% | 899,000 | +107.7% | 1.60% | +117.7% |
| Q2 2023 | $21,064,914 | +51.8% | 432,900 | +73.2% | 0.74% | +59.7% |
| Q1 2023 | $13,874,448 | -80.8% | 249,900 | -86.1% | 0.46% | -70.5% |
| Q4 2022 | $72,261,813 | -5.0% | 1,798,900 | +3.7% | 1.56% | +1.2% |
| Q3 2022 | $76,028,000 | +56.7% | 1,735,000 | +26.7% | 1.55% | +38.8% |
| Q2 2022 | $48,521,000 | -8.3% | 1,369,100 | +5.3% | 1.11% | +1.2% |
| Q1 2022 | $52,884,000 | -39.8% | 1,300,000 | +38.3% | 1.10% | -40.9% |
| Q4 2021 | $87,787,000 | +23.3% | 940,000 | +47.2% | 1.86% | +18.1% |
| Q3 2021 | $71,177,000 | +43.8% | 638,700 | +46.5% | 1.58% | +17.9% |
| Q2 2021 | $49,499,000 | +23.2% | 436,000 | +10.2% | 1.34% | +20.5% |
| Q1 2021 | $40,169,000 | -15.9% | 395,600 | -17.5% | 1.11% | -28.4% |
| Q4 2020 | $47,750,000 | +31.3% | 479,800 | -4.7% | 1.55% | -8.1% |
| Q3 2020 | $36,366,000 | – | 503,400 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |